The company will use the funds to relocate its headquarters from Maryland to Connecticut, finalize the product manufacturing process, prepare filings for U.S. Food and Drug Administration clearance and fund marketing initiatives.
The product being developed is a minimally-invasive bone graft harvesting device that intends on providing surgeons with a safe and efficient way to harvest bone grafts.
Avitus Orthopaedics is a developer of orthopedic tools.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
